Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kamaraj Palanisamy"'
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 9, Iss 1, Pp 16-21 (2017)
Aims: Carvedilol phosphate (CDP) is a nonselective beta-blocker used for the treatment of heart failures and hypertension. In this work, moisture sorption–desorption characteristics and thermodynamic properties of CDP have been investigated. Materi
Externí odkaz:
https://doaj.org/article/1ed55b0b2ba346b1abf176dc90ef5d32
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 4, Iss 1, Pp 71-79 (2015)
Rilpivirine (RPV) is a pharmaceutical drug used for the treatment of HIV infection. The drug is characterized with poor aqueous solubility and dissolution rate leading to low bioavailability of the drug. Hence, there is a need for the improvement of
Externí odkaz:
https://doaj.org/article/eb82e562734d447aa5e19697f255ecb9
Publikováno v:
International Journal of Pharmacy and Pharmaceutical Sciences. :66-71
Objective: Sitagliptin phosphate and metformin hydrochloride tablet is an FDA approved combination product for the treatment of diabetes mellitus type 2. There are no reported evidence for estimation of undesired (S)-sitagliptin in a combination prod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::601eb2a2fddb159254c34ba57cbeae97
https://doi.org/10.22159/ijpps.2019v11i6.22699
https://doi.org/10.22159/ijpps.2019v11i6.22699
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 9, Iss 1, Pp 16-21 (2017)
Journal of Pharmacy & Bioallied Sciences
Journal of Pharmacy & Bioallied Sciences
Aims: Carvedilol phosphate (CDP) is a nonselective beta-blocker used for the treatment of heart failures and hypertension. In this work, moisture sorption–desorption characteristics and thermodynamic properties of CDP have been investigated. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe0dc72433f545262a220d593c3bb90
http://www.jpbsonline.org/article.asp?issn=0975-7406
http://www.jpbsonline.org/article.asp?issn=0975-7406
Publikováno v:
HIV & AIDS Review. 15:170-176
Aim Intend of the present exertion is to prepare β-cyclodextrin (β-CD) based polymeric nanosuspension (PNS) of Efavirenz (EFV) with enhanced aqueous solubility and dissolution rate as compared to pure drug. Background EFV is a low aqueous soluble m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::503db53c5a1b29f95fee5fa79d7d0c50
https://doi.org/10.1016/j.hivar.2016.11.007
https://doi.org/10.1016/j.hivar.2016.11.007
Publikováno v:
Scientia Pharmaceutica
Volume 84
Issue 3
Pages 456-466
Volume 84
Issue 3
Pages 456-466
Efavirenz is a non-nucleoside reverse transcriptase inhibitor used in the treatment of human immunodeficiency virus type-1 (HIV). (2S)-(2-Amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluoro-3-butyn-2-ol (AMCOL), used as an intermediate in the synthes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c676504150ad0e3299a3b1a7bb5d700a
https://doi.org/10.3390/scipharm84030456
https://doi.org/10.3390/scipharm84030456
Publikováno v:
Tropical Journal of Pharmaceutical Research; Vol 14, No 9 (2015); 1549-1556
Purpose: To enhance the aqueous solubility and dissolution rate of elvitegravir (EVG) by formulating the drug as solid lipid nanoparticles (SLNs) using solvent injection method.Methods: EVG-loaded SLNs were prepared by solvent injection method. Four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d55995d37cecfc35e811a8581af697b
https://doi.org/10.4314/tjpr.v14i9.2
https://doi.org/10.4314/tjpr.v14i9.2
Publikováno v:
Journal of Taibah University for Science. 9(4):586-593
The quantitative characterisation of the solid form of drug substances and drug products is gaining importance due to product quality and performance that is based on stringent regulatory guidelines. Therefore, in this study, thermal, X-ray diffracti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2accd93c189f85cdfff73a995e97d2cc
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 4, Iss 1, Pp 71-79 (2015)
Rilpivirine (RPV) is a pharmaceutical drug used for the treatment of HIV infection. The drug is characterized with poor aqueous solubility and dissolution rate leading to low bioavailability of the drug. Hence, there is a need for the improvement of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec32c1b0667d04892d37cb7aa62dfff0
Publikováno v:
Dissolution Technologies. 22:30-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4067d3c57f9cbbac1b9f01958ba674a
https://doi.org/10.14227/dt220415p30
https://doi.org/10.14227/dt220415p30